Page last updated: 2024-08-23

etoposide and Bone Cancer

etoposide has been researched along with Bone Cancer in 286 studies

Research

Studies (286)

TimeframeStudies, this research(%)All Research%
pre-19905 (1.75)18.7374
1990's69 (24.13)18.2507
2000's100 (34.97)29.6817
2010's83 (29.02)24.3611
2020's29 (10.14)2.80

Authors

AuthorsStudies
Adachi, S; Hiramatsu, H; Kato, I; Mizowaki, T; Nakamoto, Y; Okamoto, T; Saida, S; Sakamoto, A; Shimizu, H; Takita, J; Taura, K; Umeda, K; Uto, M1
Adamczyk-Grochala, J; Betlej, G; Błoniarz, D; Lewińska, A; Rzeszutek, I; Wnuk, M1
Ghandour, K; Halalsheh, H; Ibrahimi, AKH; Ismael, T; Sarhan, N; Shehadeh, A; Sultan, I; Zandaki, D1
Lucari, B; Porea, T; Sutton, VR; Tallis, E1
Bompas, E; Brugières, L; Castex, MP; Chevreau, C; Cleirec, M; Corvest, V; Duranteau, L; Entz-Werle, N; Filhon, B; Flandrin, J; Fresneau, B; Gaspar, N; Gentet, JC; Guimard, G; Jimenez, M; Laurence, V; Le Deley, MC; Lervat, C; Mansuy, L; Marec-Bérard, P; Pacquement, H; Pondrom, M; Rousset-Jablonski, C; Saumet, L; Tabone, MD; Taque, S; Toulmonde, M; Verité, C1
Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J1
Arndt, C; Boron, M; Buxton, A; Chen, HX; Crompton, BD; Daldrup-Link, H; DuBois, SG; Eutsler, E; Glade-Bender, J; Gorlick, RG; Hayes, A; Hill-Kayser, C; Janeway, KA; Kolb, EA; Krailo, MD; Laack, N; Lessnick, SL; Rakheja, D; Randall, RL; Reed, DR; Reid, JM; Seibel, NL; Teot, L; Terezakis, S; Womer, R1
Bailey, KM; Daley, J; Friehling, E; Halligan, K; Howrie, D; Salgado, CM; Superdock, A1
Goldin, AN; Healey, RM1
Ahmed, SK; Allen-Rhoades, W; Heidenreich, MJ; Houdek, MT; Petersen, IA; Robinson, SI; Rose, PS; Siontis, BL1
Aiba, H; Arakawa, A; Imai, T; Iwata, S; Kawai, A; Kimura, H; Kobayashi, E; Kojima, Y; Ogawa, C; Shimoi, T; Sudo, K; Yazaki, S; Yonemori, K; Yoshida, A1
Binitie, O; Buxton, AB; Cash, T; DuBois, SG; Gorlick, R; Grier, HE; Grohar, PJ; Healey, JH; Janeway, KA; Krailo, MD; Marcus, KJ; Pawel, BR; Reed, DR; Weiss, AR; Womer, RB1
Abe, T; Chiba, H; Iwahara, N; Kikuchi, H; Matsumoto, R; Mitsuhashi, T; Miyata, H; Morita, K; Osawa, T; Shinohara, N; Tanaka, H1
Abdelal, S; Abu-Hijlih, R; Abuhijla, F; Almousa, A; Halalsheh, H; Ismail, T; Jaber, O; Salah, S; Shehadeh, A; Sultan, I; Yaser, S1
Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A1
Brohl, AS; Cubitt, CL; Fridley, B; Kahen, E; Reed, DR; Welch, D1
Boehme, KA; Handgretinger, R; Lenz, JE; Riester, R; Schleicher, SB; Traub, F1
He, A; Hu, H; Huang, Y; Shen, Z; Sun, Y; Yao, Y; Zhang, J; Zhou, Y1
Barlogie, B; Mouhieddine, TH; Teruya-Feldstein, J1
Anderton, J; Brennan, B; Evans, A; Fenwick, N; Fernández-Pinto, M; Gaspar, N; Gelderblom, H; Kaiser, S; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J1
Bassale, S; Davis, LE; Lim, JY; Lu, E; Ryan, CW1
Adachi, S; Akazawa, R; Arakawa, Y; Hiramatsu, H; Kato, I; Moritake, H; Okamoto, T; Saida, S; Sakamoto, A; Sumiyoshi, S; Takita, J; Umeda, K1
Bansal, D; Jain, R; Kapoor, R; Rao, KLN; Samujh, R; Saxena, AK; Totadri, S; Trehan, A1
Adam, J; Bayle, A; Briand, S; Chamseddine, AN; Court, C; Dômont, J; Dumont, SN; Even, C; Faron, M; Haddag-Miliani, L; Honoré, C; Lazure, T; Le Cesne, A; Levy, A; Lucibello, F; Mir, O; Ngo, C; Perret, A; Verret, B1
Brownridge, PJ; Campbell, AE; Corbin, EK; Eyers, CE; Ferraz Franco, C; Jones, AR; Kalyuzhnyy, A; Perkins, ND; Perkins, S; Su, LI1
Chumbalkar, V; Howe, AS; Kogan, BA; Lian, F; Nazeer, T; Pearce, J; Ribbons, L1
Bajpai, J; Banavali, SD; Bhargava, P; Chandrasekharan, A; Dandekar, S; Gupta, S; Joshi, A; Khanna, N; Laskar, S; Menon, N; Mokal, S; Noronha, V; Panda, GS; Patil, V; Prabhash, K; Rekhi, B; Srinivas, S1
Bielack, SS; Fuchs, J; Hallmen, E; Kazanowska, B; Klingebiel, T; Koscielniak, E; Ladenstein, R; Ljungman, G; Niggli, F; Paulussen, M; Scheer, M; Seitz, G; Sparber-Sauer, M; Vokuhl, C1
Cameron, AL; Elliss-Brookes, L; Fardus-Reid, F; Feltbower, RG; Fern, L; Fraser, J; Irvine, L; McCabe, MG; Pritchard-Jones, K; Shelton, J; Stiller, C; Wills, L1
Bautista, F; Campbell-Hewson, Q; Gaspar, N; Huang, J; Okpara, CE1
Agarwala, S; Bakhshi, S; Batra, A; Dhawan, D; Gupta, YK; Pramanik, R; Thulkar, S; Vishnubhatla, S1
Allinson, K; Candy, N; Carr, O; McMillen, J; Trivedi, R; Young, A1
Dean, RK; Gill, D; Nat, A; Subedi, R1
Miyagi, R; Nishisho, T; Sairyo, K; Sakaki, M; Takao, S1
Ahmed, SK; DuBois, SG; Geller, DS; Gorlick, RG; Granowetter, L; Grier, HE; Harmsen, WS; Janeway, KA; Krailo, M; Laack, NNI; Marcus, KJ; Randall, RL; Sorger, JI; Womer, RB1
Bompas, E; Bouvier, C; Brisse, HJ; Brugieres, L; Castex, MP; Cheurfa, N; Corradini, N; Delaye, J; Entz-Werlé, N; Gaspar, N; Gentet, JC; Italiano, A; Le Deley, MC; Lervat, C; Marec-Berard, P; Mascard, E; Occean, BV; Pacquement, H; Piperno-Neumann, S; Redini, F; Saumet, L; Schmitt, C; Tabone, MD; Verite-Goulard, C1
Almeida, L; Coutinho, L; Fernandes, E; Ferreira de Oliveira, JMP; Oliveira, H; Pacheco, AR; Pinho, S; Santos, C1
Dong, Y; Jiang, S; Wang, G1
Allan, E; Hanna, F; Khalafallah, AA; Prakash, A1
Sun, D; Tang, Y; Yao, J; Zhang, M; Zhao, H; Zhu, Z1
Bagherifard, A; Jamshidi, K; Mirzaei, A; Ramezan Shirazi, M1
Aguiar, S; Batista, RMSS; de Cássio Zequi, S; Lopes, A; Mourão, TC1
Azmy, V; Brooks, JP; Hsu, FI; Luon, D; Price, C; Prozora, SD; Thompson, A1
Burchill, SA; Jabri, S; Roundhill, EA1
Abboud, MR; Abou Ali, B; Akel, S; Boulos, F; El-Solh, H; Ghanem, KM; Haidar, R; Muwakkit, SA; Saab, R; Saghieh, S; Salman, M; Tamim, H1
Bajpai, J; Banavali, S; Chandrasekharan, A; Ghosh, J; Gupta, S; Hingmare, S; Mandal, T; Rangarajan, B; Rekhi, B; Shah, K; Shetty, N; Simha, V; Vora, T1
Banavali, S; Devadas, SK1
Anract, P; Bertucci, F; Blay, JY; Bompas, E; Brugieres, L; Collard, O; Cupissol, D; de Pinieux, G; Delaye, J; Duffaud, F; Italiano, A; Laurence, V; Le Cesne, A; Le Deley, MC; Occean, BV; Penel, N; Perrin, C; Piperno-Neumann, S; Ray-Coquard, I; Rios, M1
Kok, MK; Nakagawa, T; Nishimura, R; Ong, SM; Saeki, K1
Arai, E; Futamura, N; Hirata, A; Ishiguro, N; Kozawa, E; Miyahara, R; Nishida, Y; Tsukushi, S; Tsurudome, I; Urakawa, H1
Ara, T; Buettner, R; DeClerck, YA; Groshen, SG; Ji, L; Jove, R; Nakata, R; Seeger, RC; Sheard, MA; Shimada, H; Yu, H1
Angarita, FA; Meek, E; Rodríguez, JL; Sánchez, JO; Tawil, M; Torregrosa, L1
Al-Hader, AA; Al-Nasrallah, N; Einhorn, LH; Jain, A1
Abate, ME; Balladelli, A; Cesari, M; Fagioli, F; Ferrari, S; Luksch, R; Marchesi, E; Paioli, A; Palmerini, E; Pratelli, L; Tamburini, A1
Fernández de Gamarra Martínez, E; Mangues Bafalluy, MA; Mullera Martí, M; Riba Solé, M1
Brennan, B; Craft, A; Dirksen, U; Hjorth, L; Judson, I; Juergens, H; Ladenstein, R; Le Deley, MC; Le Teuff, G; Lewis, I; Marec-Bérard, P; Michon, J; Oberlin, O; Paulussen, M; Ranft, A; van den Berg, H; Wheatley, K; Whelan, J1
Benson, C; Blay, JY; Dirksen, U; Gelderblom, H; Judson, I; Juergens, H; Placzke, J; Rasper, M; Rutkowski, P; van den Berg, H; van Maldegem, AM1
Fu, WM; Hsieh, IS; Yang, RS1
Wang, W; Wang, Z; Xiao, X1
Anninga, J; Bernstein, M; Bielack, SS; Böhling, T; Butterfass-Bahloul, T; Calaminus, G; Capra, M; Deffenbaugh, C; Dhooge, C; Eriksson, M; Flanagan, AM; Gelderblom, H; Goorin, A; Gorlick, R; Gosheger, G; Grimer, RJ; Hall, KS; Helmke, K; Hogendoorn, PC; Hook, JM; Jovic, G; Jundt, G; Kager, L; Krailo, M; Kuehne, T; Lau, CC; Letson, GD; Marina, N; Meyer, J; Meyers, PA; Morris, C; Mottl, H; Nadel, H; Nagarajan, R; Randall, RL; Schomberg, P; Schwarz, R; Smeland, S; Sydes, MR; Teot, LA; Whelan, JS1
Benassi, MS; Conti, A; Novello, C; Pazzaglia, L; Perego, P; Picci, P; Pollino, S; Quattrini, I1
Anurathapan, U; Choeyprasert, W; Chuansumrit, A; Hongeng, S; Nartthanarung, A; Pakakasama, S; Sirachainan, N; Songdej, D1
Agarwala, S; Bakhshi, S; Biswas, B; Deo, SV; Khan, SA; Mohanti, BK; Rastogi, S; Sharma, MC; Shukla, NK; Vishnubhatla, S1
Allen, PK; Arzu, I; Dabaja, B; Fayad, LE; Medeiros, LJ; Oki, Y; Pinnix, CC; Reed, VK; Rodriguez, A; Shihadeh, F; Tao, R; Westin, JR1
Wang, B; Xu, M; Xu, SF; Yu, XC1
Abujamra, AL; Almeida, MT; Benites, E; Boldrini, E; Brunetto, AL; Castillo, LA; Costa, C; Gadelha, A; Gregianin, LJ; Kirst, D; Macedo, CD; Morais, V; Nakasato, A; Pereira, WV; Petrilli, AS; Pizza, M; Rodriguez-Galindo, C; Watanabe, FM1
Bora, HK; Chaudhary, D; Khedgikar, V; Konwar, R; Kumar, A; Kushwaha, P; Mathur, V; Mishra, PR; Shukla, P; Teja, VB; Trivedi, R1
Clemens, D; Dirksen, U; Frühwald, MC; Fulda, S; Heinicke, U; Hotfilder, M; Potratz, JC; Unland, R; Wardelmann, E1
Beck, JF; Becker, S; Blümel, L; Blumrich, A; Kahl, M; Krämer, OH; Siranjeevi, PM; Sonnemann, J; Winkler, R; Wittig, S1
Abriola, L; Fernandez, RJ; Glazer, PM; Hoyer, D; Hungerford, W; Liu, Y; Merkel, J; Peterson-Roth, E; Pike, LR; Qian, JM; Stachelek, GC1
DuBois, SG; Felgenhauer, J; Granowetter, L; Grier, HE; Karski, EE; Krailo, M; Marina, N; McIlvaine, E; Meyers, PA; Segal, MR; Womer, RB1
Ash, S; Cohen, IJ; Issakov, J; Kollender, Y; Shkalim-Zemer, V; Toledano, H; Yaniv, I1
Bakhshi, S; Batra, A; Khan, SA; Nataraj, V; Rastogi, S; Sharma, MC; Vishnubhatla, S1
Bernstein, ML; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Healey, JH; Krailo, MD; Lipshultz, SE; Meyers, PA; Sato, JK; Schwartz, CL; Steinherz, LJ; Teot, LA; Wexler, LH1
Caporossi, D; Fidaleo, M; Miñana, B; Paronetto, MP; Svetoni, F; Volpe, E1
Ferrari, S; Serra, M1
Bond, MC; Felgenhauer, JL; Femino, JD; Gorlick, R; Krailo, MD; Laack, NN; Marina, N; Mascarenhas, L; Meyer, J; Ranganathan, S; Villaluna, D; Womer, RB1
Ben-Ami, T; Fried, I; Marc, W; Revel-Vilk, S; Waldman, E; Weintraub, M1
Boehme, KA; Handgretinger, R; Kluba, T; Nitsch, J; Riester, R; Schleicher, SB; Traub, F1
Nakagawa, T; Nishimura, R; Ong, SM; Saeki, K; Tanaka, Y1
Benator, D; Lim, J; Lucar, J; Tuck, M1
Almeida, L; Coutinho, L; Ferreira de Oliveira, JM; Oliveira, H; Pacheco, AR; Pimentel, F; Santos, C1
Deng, Z; Li, S; Qiu, B; Wang, L; Yang, F; Zhang, S; Zhang, T; Zhu, S1
Arndt, CA; Hawkins, DS; Hoots, WK; Inwards, CY; Kleinerman, ES; Koshkina, NV; Morales-Arias, JA; Munsell, MF; Rodriguez, NI1
Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A1
Bohr, VA; Christmann, M; Gestrich, C; Kaina, B; Roos, WP; Tomicic, MT1
Arpaci, F; Ataergin, S; Beyzadeoglu, M; Komurcu, S; Oysul, K; Ozet, A; Ozturk, M; Solchaga, L; Surenkok, S; Turan, M1
Osanai, T; Sugawara, M; Tsuchiya, T1
Adam, Z; Bolcák, K; Cerný, J; Fakan, F; Hájek, R; Krejcí, M; Kren, L; Mayer, J; Neubauer, J; Pour, L; Smardová, L; Soumarová, R; Vanícek, J; Veselý, K1
Arndt, CA; Bernstein, M; Devidas, M; Dickman, P; Gebhardt, M; Goorin, A; Granowetter, L; Grier, HE; Healey, J; Krailo, M; Leavey, P; Marcus, K; Marina, N; Meyer, J; Miser, J; Perlman, E; Sailer, S; Shamberger, RC; Wang, C; Womer, R1
Adalberto, Bdel P; Aglietta, M; Aliberti, S; Berger, M; Biasin, E; Brach del Prever, A; Eleonora, B; Fagioli, F; Ferrari, S; Franca, F; Francesco, S; Giovanni, G; Grignani, G; Massimo, A; Massimo, B; Saglio, F; Sandra, A; Stefano, F1
Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M1
Hayashi, K; Kimura, H; Nishida, H; Ohnari, I; Shirai, T; Takeuchi, A; Tomita, K; Tsuchiya, H1
Cai, JY; Chen, J; Dong, L; Jiang, H; Pan, C; Shen, SH; Tang, JY; Xu, M; Xue, HL; Ye, QD; Zhou, M1
Andreoiu, M; Beck, SDW; Brames, MJ; Cheng, L; Ehrlich, Y; Einhorn, LH; Foster, RS; Ulbright, TM1
Feng, FY; Liu, P; Qin, Y; Shi, YK; Xing, PY1
Aliev, MD; Chernov, IS; Machak, GN; Meluzova, OM; Polotskiĭ, BE1
Buchbinder, D; Casillas, J; Linetsky, M; Steinberg, G1
Gan, M; Mao, N; Shi, Q; Yang, H; Zhu, X; Zou, J1
Gibbs, CP; Indelicato, DJ; Islam, S; Keole, SR; Lagmay, JP; Marcus, RB; Morris, CG; Scarborough, MT1
Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T1
Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y1
Ferreti Bonan, PR; Martelli-Júnior, H; Miranda Soares, PB; Pereira DE Souza, W; Quirino Filho, S1
Brookes, KE; Dive, C; Holt, SV; Makin, GW1
Brammer, JE; Lulla, P; Lynch, GR1
Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY1
Cassier, P; Chapet, O; Chekrine, T; De Bari, B; Kulisa, M; Mornex, F1
Douer, D; Liu, SV; Tahbaz, A; Zneimer, S1
Braquet, P; Chapelle, A; Jorgensen, C; Pers, YM1
Acar, H; Aydemir, E; Bayrak, OF; Gulluoglu, S; Ozen, M; Sahin, F; Sevli, S; Yalvac, ME1
Cho, YJ; Duk Lee, J; Go, SI; Hwang, YS; Jeong, YY; Kim, DC; Kim, HC; Ko, GH; Lee, GW; Lee, JH; Lee, JS; Oh, S; Yang, JW1
Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ1
Ford, HL; Jedlicka, P; McKinsey, E; Reaves, L; Robin, TP; Smith, A1
Abate, ME; Barbieri, E; Bisogno, G; Daolio, P; Eriksson, M; Fagioli, F; Ferrari, S; Gandola, L; Grignani, G; Hall, KS; Lindholm, P; Luksch, R; Picci, P; Podda, M; Prete, A; Ruggieri, P; Smeland, S; Tamburini, A; Tienghi, A1
Gafton, GI; Gudz', IuV; Ivanova, TV; Krzhivitskiĭ, PI; Kupatadze, DD; Lazareva, IuR; Levchenko, EV; Nabokov, VV; Novik, VI; Petrov, VG; Punanov, IuA; Safonova, SA1
Ishii, Y; Kumita, S; Kuribayashi, S; Matsuno, A; Yamada, S; Yamada, SM1
Ash, S; Cohen, IJ; Feinmesser, M; Kornreich, L; Kuperman, AA; Yaniv, I1
Feng, DP; Gong, WH; Huang, T; Jiang, GJ; Li, XC; Li, XH; Zou, CP1
Andersen, CY; Birkebæk, NH; Clausen, N; Ernst, E; Kjærsgaard, M1
Dickman, PS; Dormans, JP; Grier, HE; Healey, JH; Krailo, MD; Marcus, K; Pawel, BR; Sailer, S; Weiss, AR; West, DC; Womer, RB1
Aït-Oukhatar, CM; Baunin, C; Benboubker, L; Brisse, H; Couanet, D; Cupissol, D; Defachelles, AS; Laurence, V; Oberlin, O; Ollivier, L; Owens, C; Rey, A; Rubie, H1
Agata, M; Kato, M; Nakayama, M; Yoshida, K1
Boulares, AH; Sherif, ZA; Smulson, ME; Yakovlev, AG; Zoltoski, AJ1
Iwamoto, Y; Matsuda, S; Matsunobu, T; Sakamoto, A; Tanaka, K1
Ben-Schachar, M; Epelbaum, R; Haim, N; Kuten, A; Stein, ME; Zaidan, J1
Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ2
Baeksgaard, L; Sørensen, JB1
Bacci, G; Longhi, A; Macchiagodena, M; Vitali, G1
al Rabi, N; Artibani, W; Dalpiaz, O; Ficarra, V; Galfano, A; Martignoni, G1
Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG1
Cook, JL; Iklé, DN; Lewis, AM; Miura, TA; Routes, JM1
Brodak, M; Louda, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Rydel, L; Simakova, E; Vaculikova, M; Veselsky, Z; Zoul, Z1
Burdach, S; Dunst, J; Finke, R; Gadner, H; Göbel, U; Haase, R; Haerting, J; Juergens, H; Laws, HJ; Metzner, B; Meyer-Bahlburg, A; Pape, H; van Kaik, B; Wawer, A1
Chang, TT; Chang, WH; Chen, RL; Hsiao, TC; Hung, IJ; Lin, DT; Lin, KH; Lin, KS; Lin, MT; Lu, MY; Shu, SG; Wu, CT; Yang, CP; Yang, RS1
Gorlick, R; Healey, JH; Huvos, AG; Kolb, EA; Kushner, BH; LaQuaglia, MP; Laverdiere, C; Meyers, PA; Qin, J; Vu, HT; Wexler, L; Wolden, S1
Boehm, R; Joppich, I; Landes, J; Schmid, I; Till, H1
Bouralexis, S; Evdokiou, A; Findlay, DM; Hay, S; Labrinidis, A1
Goto, H; Hanibuchi, M; Miki, T; Sone, S; Uehara, H; Yano, S; Zhang, H1
Göbel, U; Laws, HJ; Pape, H; Paulussen, M; van Kaick, B1
Alamanis, C; Constantinidis, C; Deliveliotis, C; Dimopoulos, MA; Giannopoulos, A; Gika, D; Kiamouris, C; Koutsilieris, M; Zervas, A1
Li, FB; Liao, WM; Liu, ZC; Zhou, JM; Zhu, JJ; Zhu, XF1
Fujinami, K; Fukuoka, H; Ikeda, I; Kawakami, S; Miura, T; Takizawa, A1
Bing, Z; Eltorky, MA; Hatch, SS; Levine, L; Lucci, JA1
Fujisawa, M; Hara, I; Kamidono, S; Kanomata, N; Kawabata, G; Kumano, Y; Takeda, M; Tanaka, K1
deVere White, RW; Ellison, LM; Gandour-Edwards, R; Goldberg, Z; Karpman, E; Saffarian, A1
Guo, W; Li, DS; Tang, S; Tang, XD; Yang, RL; Yang, Y1
Chuman, H1
Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C1
Akansel, G; Arisoy, AE; Calişkan, M; Corapcioglu, F; Dillioğlugil, O; Sarper, N1
Allam, A; Bazarbashi, S; El Foudeh, M; El Hassan, I; El Weshi, A; Ezzat, A; Memon, M; Pai, C; Rahal, M; Raja, M1
Argon, A; Basaran, M; Bavbek, SE; Camlica, H; Darendeliler, E; Dizdar, Y; Onat, H; Ozger, H; Sakar, B; Yaman, F1
Berta, M; Bertoni, F; del Prever, AB; Fagioli, F; Ferrari, S; Mercuri, M1
Allen, K; Barth, NM; Beutel, LD; Chico, S; Dillman, RO; VanderMolen, LA1
Alapetite, C; Anract, P; Babinet, A; Barthier, S; de Pinieux, G; Laurence, V; Palangié, T; Pierga, JY; Pouillart, P1
Debes, A; Göbel, U; Wessalowski, R; Willers, R1
Bamias, A; Briasoulis, E; Christodoulou, C; Dimopoulos, MA; Fountzilas, G; Kalofonos, H; Kosmidis, P; Makatsoris, T; Pavlidis, N; Samantas, E; Skarlos, D1
Hobson, R; Morland, B; Ng, A; Williams, D1
Brodsky, I; Rosenbluth, JZ; Styler, MJ; Zak, D1
Alektiar, KM; Boland, PJ; Healey, JH; La, TH; Laquaglia, MP; Meyers, PA; Wexler, LH; Wolden, SL1
Lewis, I; McTiernan, A; Meyer, T; Michelagnoli, MP; Whelan, JS1
Dai, J; Guo, Y; Jin, J; Shi, M; Wang, R; Wu, M; Zhang, X; Zhao, J1
Li, FB; Liao, WM; Zhu, JJ; Zhu, XF1
Imoto, I; Inazawa, J; Katsuki, Y; Mizutani, S; Nagasawa, M; Nakada, S; Yokoyama, T1
Fujimoto, K; Hirao, Y; Hirayama, A; Matsushita, C; Miyake, M; Nonomura, A; Takashima, K; Tanaka, M1
Boldrini, R; Cozza, R; De Ioris, M; De Sio, L; Dominici, C; Donfrancesco, A; Ilari, I; Inserra, A; Jenkner, A; Milano, GM1
Billups, CA; Cain, AM; Furman, WL; Hale, GA; Merchant, TE; Navid, F; Pappo, AS; Rao, BN; Santana, VM; Spunt, SL1
Craft, A; Juergens, C; Juergens, H; Lewis, I; Michon, J; Oberlin, O; Paulussen, M; Weston, C; Whelan, J; Zoubek, A1
Mai, WY; Nguyen, TX; Paulino, AC; Teh, BS; Wen, BC1
Driver, D; Kilby, AM; McTiernan, A; Michelagnoli, MP; Whelan, JS1
Bogdanos, J; Dimopoulos, P; Dimopoulos, T; Halapas, A; Karamanolakis, D; Katopodis, H; Koutsilieris, M; Lembessis, P; Milathianakis, C; Papageorgiou, E; Pissimissis, N; Pitulis, N; Sourla, A; Tenta, R1
Guo, W; Tang, S; Tang, XD; Yang, Y1
Katski, K; Kołłataj, B; Kołłataj, W; Majewski, M; Pijanowska, M; Sikora, P; Zajaczkowska, M1
Katakami, N1
Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI1
Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ1
Cai, Y; Wang, WL; Xu, B; Zhang, SW; Zhu, GY1
Naru, T; Nawaz, FH; Rizvi, J1
Abe, S; Ishii, T; Kawai, A; Matsumine, A; Obata, H; Ozaki, T; Tanaka, K; Tsuchiya, H; Ueda, T; Yabe, H1
Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A1
Brugières, L; Dupoüy, N; Entz-Werlé, N; Gentet, JC; Guinebretière, JM; Kalifa, C; Le Deley, MC; Marec-Bérard, P; Pacquement, H; Pichon, F; Schmitt, C; Tabone, MD; Vanel, D1
Aboody, KS; Gevorgyan, A; Gutova, M; Metz, MZ; Najbauer, J; Shih, CC; Weng, Y1
Burke, MJ; Duerst, RE; Jacobsohn, DA; Kletzel, M; Walterhouse, DO1
Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M1
Cooney, KA; Dunn, RL; Fardig, JE; Mackler, NJ; Olson, KB; Pienta, KJ; Redman, BG; Smith, DC1
Chiba, N; Gamoh, M; Ishioka, C; Kakudo, Y; Kato, S; Murakawa, Y; Nishino, Y; Ohori, H; Ohtsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Suzuki, T; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T1
Billups, CA; Krasin, MJ; Liu, T; Navid, F; Rao, BN; Rodríguez-Galindo, C1
Alimirah, F; Chen, J; Choubey, D; Ho, SM; Panchanathan, R; Zhang, X1
Chen, ZX; Deng, R; Fan, Q; Feng, GK; He, AS; Huang, XF; Liang, SG; Liao, WM; Sheng, PY; Yang, ZB; Yuan, XW; Zhu, XF1
Anderson, P; Chang, EL; Herzog, CE; Hughes, D; Huh, W; Kornguth, DG; Mahajan, A; Pelloski, CE; Woo, SY1
Cheerva, AC; Gross, TG; Kadota, RP; Levine, JE; Ozkaynak, MF; Richards, MK; Rozans, MK; Sahdev, I; Shaw, PJ1
Almasan, A; Banerjee, D; Bertino, JR; Fan, J; Hochhauser, D; Kelly, R; Li, W; Wahl, GM; Yin, Y; Zielinski, Z1
Advani, SH; Badrinath, Y; Bajpai, S; Gladstone, B; Kapoor, G; Nair, CN1
Lokich, J1
Appel, C; Cummings, G; Esper, PS; Flaherty, LE; Hussain, M; Pienta, KJ; Redman, B1
Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M1
de Mulder, PH; de Pauw, M; de Wit, R; Kaye, SB; Sleijfer, DT; Spaander, PJ; Stoter, G; Sylvester, R; ten Bokkel Huinink, WW1
Bezwoda, WR; Dansey, RD; Seymour, L1
Hamada, M; Inoue, H; Nakagawa, Y; Ozaki, T; Sugihara, S1
Inagaki, T; Touge, H; Uekado, Y; Watanabe, T1
Cowie, FJ; Dick, G; Flanagan, RJ; Judson, I; McCarthy, PT; Phillips, M; Pinkerton, CR1
Andoh, S; Fujisawa, Y; Hasegawa, Y; Itoh, K; Kotoh, S; Kumazawa, J; Naito, S; Omoto, T; Sagiyama, K; Ueda, T1
Castel, V; Esquembre, C; Ferrís, J; Lopez-Andrew, JA; Senent, ML; Verdeguer, A1
Elomaa, I1
Ayass, M; Cassano, W; Dickson, N; Enneking, W; Graham-Pole, J; Heare, M; Heare, T; Marcus, R; Saleh, R; Spanier, S1
Burdach, S; Dilloo, D; Jürgens, H; Körholz, D; Koscielniak, E; Mauz-Körholz, C; Nürnberger, W; Pape, H; Paulussen, M; Peters, C1
Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB1
Bacci, G; Barbieri, E; Casadei, R; Fabbri, N; Ferrari, S; Ferraro, A; Mercuri, M; Picci, P; Rosito, P; Ruggieri, P1
Crown, J; Currie, V; Gilewski, T; Hakes, T; Hudis, C; Lebwohl, D; Reichman, B; Seidman, A; Surbone, A; Yao, TJ1
Imoto, M; Kakusui, M; Kashima, K; Misawa, S; Takashima, T; Taniwaki, M1
Barrantes, JC; García, I; Lobo-Sanahuja, F; Santamaría, S1
Carstens, C; Lowry, PA1
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA1
Fujioka, S; Kato, K; Tomono, H1
Bacci, G; Barbieri, E; Brach del Prever, A; Campanacci, M; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P1
Avila, N; Balis, FM; DeLaney, TF; Hijazi, YM; Horowitz, ME; Jacobson, J; Jarosinski, P; Steinberg, SM; Tsokos, M; Weaver-McClure, L; Wexler, LH1
Hetzel, DJ; Mortel, R; Olt, GJ; Podczaski, ES; Singapuri, K; Sorosky, JI1
Asano, K; Iizuka, N; Ohishi, Y; Onodera, S; Takeuchi, H; Tashiro, K; Wada, T; Yanada, S1
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M1
Leo, E; Lindemann, A; Schlegel, PG1
Avet-Loiseau, H; Berger, C; Bernard, JL; Brunat-Mentigny, M; De Lumley, L; Demaille, MC; Gentet, JC; Kalifa, C; Pacquement, H; Pein, F; Pillon, P; Sariban, E; Schmitt, C1
Colleoni, M; Graiff, C; Manente, P; Nelli, P; Pancheri, F; Sgarbossa, G; Vicario, G1
Bacci, G; Barbieri, E; Brach Del Prever, A; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P; Ruggieri, P1
Etoh, Y; Imamura, H; Kamio, T; Nogami, T; Nomura, H; Saeki, T; Sakai, K; Suko, H; Suko, S; Tokunaga, H1
Fisher, C; Harmer, CL; Judson, IR; Thomas, JM; Verrill, MW; Wiltshaw, E1
Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M1
Ben Arush, MW; Drumea, K; Haim, N; Kuten, A; Meller, I; Moses, M; Stein, ME1
Bacci, G; Barbieri, E; Brach del Prever, A; Ferrari, S; Forni, C; Mercuri, M; Picci, P; Rosito, P; Tienghi, A1
Bacci, G; Bertoni, F; Briccoli, A; Campanacci, M; Cesari, M; Fabbri, N; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M1
Constine, LS; Hicks, DG; O'Keefe, R; Packman, CH; Rapoport, AP; Rosier, RN; Rowe, JM; Rubin, SJ1
Horiuchi, S; Negishi, T; Tsukamoto, T; Urushibara, M1
Benjamin, RS; Gano, J; Gianan, MA; Jaffe, N; Jia, SF; Kleinerman, ES; Papadopoulos, NE; Patel, S; Raymond, AK; Rodriguez, C; Worth, LL1
Enneking, WF; Lindner, NJ; Scarborough, MT; Spanier, SS1
Ahrens, S; Dunst, J; Hillmann, A; Hofmann, J; Jürgens, H; Paulussen, M; Rübe, C; Schuck, A; Willich, N1
Idezuki, Y; Ishizuka, N; Kobayashi, M; Murata, N; Suwata, J; Takada, S1
Ambrosch, G; Huber, H; Mohn-Staudner, A; Oberaigner, W; Oroszy, S; Pfeifer, W; Pirker, R; Prior, C1
Bailey, CC; Gattamaneni, HR; Lashford, LS; Lewis, IJ; Michelagnoli, MP1
El-Deiry, WS; Enders, GH; Herlyn, M; Prabhu, NS; Satyamoorthy, K; Somasundaram, K; Tian, H1
Cain, AM; Greenwald, C; Marina, NM; Meyer, WH; Pappo, AS; Parham, DM; Poquette, CA; Pratt, CB; Rao, BN1
Felgenhauer, J; Hawkins, D; Radich, J; Thomson, B1
Esper, P; Pienta, KJ; Redman, B; Smith, DC; Strawderman, M1
Bacchini, P; Bacci, G; Bertoni, F; Donati, D; Ferrari, S; Forni, C; Longhi, A; Manfrini, M; Picci, P; Rimondini, S1
Bashey, A; Corringham, RE; Corringham, S; Garrett, J; Gilpin, EA; Ho, AD; Lane, TA; Law, P1
Daller, RT; Fenton, JG; Miser, JS; Womer, RB1
Bonneu, A; Chauvot, P; Edeline, V; Frappaz, D; Giammarile, F; Gomez, F; Siles, S; Wioland, M1
Anthony, LB; Drouant, G; Espanan, GD; Maloney, TJ; McCarthy, KE; Meyers, MO; Woltering, EA1
Fraser, G; Nicoll, J; Rampling, R; Smith, C; Stephen, M1
Bacci, G; Bertoni, F; Campanacci, M; Casadei, R; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Picci, P; Ruggieri, P; Versari, M1
Kushner, BH; Meyers, PA1
Böhm, P; Einsele, H; Horny, HP; Kunz, W1
Brandao, L; Cain, AM; Kun, LE; McCarville, MB; Pappo, AS; Poquette, CA; Spunt, SL1
Beck, JD; Greil, J; Hertzberg, H; Kremens, B; Velten, I1
Baker, DL; Chan, KW; Davis, JH; Dickman, PS; Gerbing, RB; Gorlick, RG; Grovas, A; Herzog, CE; Krailo, MD; Ladanyi, M; Lindsley, KL; Liu-Mares, W; Meyers, PA; Nachman, JB; Sailer, SL; Sieger, L; Wadman, J1
Dong, YB; Elliott, MJ; McMasters, KM; Wong, SL; Yang, HL1
Cole, M; Ellershaw, C; Lewis, IJ; Pearson, AD; Pinkerton, CR; Tweddle, DA1
Bernstein, M; Devidas, M; Ferguson, W; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Link, M; Schwartz, CL; Siegal, GP1
Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A1
Boletis, J; Chiras, T; Kosmas, C; Kostakis, A; Tsavaris, NB; Vadiaka, M1
Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K1
Aglietta, M; Bacci, G; Biasin, E; Brach del Prever, A; Fagioli, F; Ferrari, S; Madon, E; Palmero, A; Picci, P; Tienghi, A; Vassallo, E1
Daw, NC; Dome, JS; Kaste, SC; Meyer, WH; Pappo, AS; Pratt, CB; Rao, BN; Rodríguez-Galindo, C1
Ahrens, S; Dunst, J; Jürgens, H; Könemann, S; Paulussen, M; Rübe, C; Rübe, CE; Schuck, A; Willich, N1
Black, T; Estrada-Aguilar, J; Greenberg, H; Hvizdala, E; Morse, S; Schroer, K; Walling, A1
Bornhoeft, G; Dieckmann, KP; Gross, AJ1
Fletcher, B; Kun, L; Marina, N; Meyer, WH; Parham, D; Pratt, CB; Rao, B; Roberson, P1
Gedikoğlu, G; Zülfikar, B1
Ash, RC; Beatty, PA; Lundberg, JH; Weissman, DE1
Baba, H; Tomita, K; Tsuchiya, H; Ueda, Y; Yasutake, H; Yokogawa, A1
Atikachai, B; Jiemsripong, K; Phothirat, C; Thongprasert, S1
Burdach, S; Dilloo, D; Gadner, H; Göbel, U; Nürnberger, W; Paulussen, M; Peters, C; Voehringer, R; Wernet, P; Wurm, R1
Cantwell, B; Fossà, SD; Harding, MJ; Jones, WG; Lewis, CR; Mead, G; Mill, L; Paul, J; Rodenburg, CJ; ten Bokkel Huinink, W1
Fujita, K; Hibi, S; Imashuku, S; Miyake, M; Nakajima, F; Todo, S1
Hovi, L; Saarinen, UM; Sariola, H1
Avella, M; Bacci, G; Dallari, D; De Cristofaro, R; Ferruzzi, A; Manfrini, M; Marangolo, M; Mercuri, M; Picci, P; Pignatti, G1
Akiba, Y; Fujita, Y; Ikushima, Y; Ishida, S; Ohosaki, Y; Onodera, S; Sakai, E; Saotome, K; Shimizu, T; Tagaki, S1
Cassano, WF; Dickson, N; Graham-Pole, J1
Morikawa, Y; Tanaka, S1
Fletcher, BD; Jenkins, JJ; Lemmi, MA; Marina, NM; Meyer, WH; Parham, DM; Slade, W1
Aihara, T; Hanada, R; Hayashi, Y; Hirata, A; Imaizumi, S; Inaba, T; Miyakawa, T; Sugawara, T; Yaginuma, A; Yamamoto, K1
Bacchi, M; Bassi, P; Belsanti, V; Bisagni, G; Boni, C; Cocconi, G; Lottici, R; Passalacqua, R; Tonato, M1
Abbot, F; Cassano, W; Dickson, N; Graham-Pole, J; Heare, M; Heare, T; Kedar, A; Metha, P; Saleh, RA; Vander Griend, R1
Pinkerton, CR; Pritchard, J; Spitz, L1
Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D1
Kobayasi, S; Nakagawa, M; Sasamoto, H; Seki, T; Tsuruta, A; Yamaji, T1
Shiu, WC; Tsao, SY1
Achterrath, W; Fink, U; Meyer, HJ; Meyer, J; Neuhaus, P; Preusser, P; van de Loo, J; Wilke, H1

Reviews

24 review(s) available for etoposide and Bone Cancer

ArticleYear
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
    Japanese journal of clinical oncology, 2023, Jun-29, Volume: 53, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Prognosis; Progression-Free Survival; Sarcoma, Ewing; Skin Neoplasms; Vincristine

2023
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
    Current oncology (Toronto, Ont.), 2019, Volume: 26, Issue:4

    Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2019
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
    Paediatric drugs, 2014, Volume: 16, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids

2014
An update on chemotherapy for osteosarcoma.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:18

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic

2015
Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta-Analysis.
    Journal of cellular biochemistry, 2018, Volume: 119, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Sarcoma, Ewing; Survival Rate

2018
[Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation].
    Vnitrni lekarstvi, 2009, Volume: 55, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carmustine; Cytarabine; Dendritic Cell Sarcoma, Interdigitating; Drug Resistance, Neoplasm; Etoposide; Humans; Leg; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Soft Tissue Neoplasms; Tibia; Tomography, X-Ray Computed

2009
[Clinical characteristics and treatment of desmoplastic small round cell tumor].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:2

    Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiotherapy, Conformal; Surgical Procedures, Operative; Survival Rate; Vincristine; Young Adult

2010
[Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2011, Volume: 15, Issue:3

    Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma in Situ; Carcinoma, Neuroendocrine; Carcinoma, Transitional Cell; Combined Modality Therapy; Emergencies; Etoposide; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Prognosis; Prostatic Hyperplasia; Topoisomerase I Inhibitors; Topotecan; Urinary Bladder Neoplasms

2011
Advanced therapeutic strategy for radiation-induced osteosarcoma in the skull base: a case report and review.
    Radiation oncology (London, England), 2012, Aug-10, Volume: 7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Radiation-Induced; Osteosarcoma; Prognosis; Skull Base Neoplasms

2012
Small cell carcinoma of the bladder: a case report and a literature review.
    Archivos espanoles de urologia, 2003, Volume: 56, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Life Tables; Liver Neoplasms; Male; Middle Aged; Stevens-Johnson Syndrome; Survival Analysis; Urinary Bladder Neoplasms; Vincristine

2003
[A case of well controlled renal small cell carcinoma with metastasis treated by intensive therapy].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2004, Volume: 95, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Kidney Neoplasms; Male; Nephrectomy

2004
Primary small cell neuroendocrine carcinoma of the vagina: a clinicopathologic study.
    Archives of pathology & laboratory medicine, 2004, Volume: 128, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brachytherapy; Carcinoma, Small Cell; Chromogranin A; Chromogranins; Cisplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Hemorrhage; Humans; Keratins; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Radioisotope Teletherapy; Synaptophysin; Thyroid Nuclear Factor 1; Transcription Factors; Vaginal Diseases; Vaginal Neoplasms

2004
Oncocytic adrenocortical carcinoma.
    Urology, 2004, Volume: 64, Issue:2

    Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Embolization, Therapeutic; Etoposide; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitotane; Nephrectomy; Ribs; Tomography, X-Ray Computed

2004
Analysis of treatment for small cell cancer of the bladder and report of three cases.
    Urology, 2004, Volume: 64, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Biomarkers, Tumor; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease Progression; Etoposide; Gemcitabine; Humans; Life Tables; Liver Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Second Primary; Prostatectomy; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion

2004
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids

2004
Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Carmustine; Cisplatin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prognosis; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2005
Anaplastic large cell lymphoma of bone--is it a bad tumor?
    Pediatric blood & cancer, 2007, Volume: 48, Issue:4

    Topics: Activin Receptors, Type II; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Prognosis; Remission Induction; Scapula; Treatment Outcome; United Kingdom

2007
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
    Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Etoposide; Femoral Neoplasms; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Palliative Care; Salvage Therapy; Scalp; Skin Neoplasms; Thoracotomy

2005
Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:7

    Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Dexamethasone; Drug Resistance, Neoplasm; Estramustine; Etoposide; Gonadotropin-Releasing Hormone; Growth Substances; Humans; Leuprolide; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Orchiectomy; Osteoblasts; Osteoclasts; Paracrine Communication; Peptides, Cyclic; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Receptors, Androgen; Salvage Therapy; Somatostatin; Survival Analysis; Triptorelin Pamoate

2006
Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.
    The American journal of pediatric hematology/oncology, 1994, Volume: 16, Issue:4

    Topics: Bone Neoplasms; Child; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Pelvic Bones; Sarcoma, Ewing; Teniposide

1994
An update of Scandinavian studies of osteosarcoma.
    Cancer treatment and research, 1993, Volume: 62

    Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome

1993
Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
    Cancer treatment and research, 1993, Volume: 62

    Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Florida; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Life Tables; Lung Neoplasms; Methotrexate; Osteosarcoma; Survival Analysis; Treatment Outcome

1993
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Melphalan; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Thiotepa; Vincristine; Whole-Body Irradiation

2001
Adult Gaucher disease in association with primary malignant bone tumors.
    Cancer, 2001, Feb-01, Volume: 91, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Male; Prednisone; Radiography; Vincristine

2001

Trials

75 trial(s) available for etoposide and Bone Cancer

ArticleYear
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
    International journal of cancer, 2023, 04-15, Volume: 152, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine

2023
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
    Lancet (London, England), 2022, 10-29, Volume: 400, Issue:10362

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine

2022
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 04-10, Volume: 41, Issue:11

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine

2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023, 10-20, Volume: 41, Issue:30

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Doxorubicin; Etoposide; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine

2023
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
    Trials, 2020, Jan-17, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Busulfan; Child; Child, Preschool; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult; Zoledronic Acid

2020
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS).
    Pediatric blood & cancer, 2021, Volume: 68, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Prospective Studies; Sarcoma, Ewing; Vincristine; Young Adult

2021
OLIE, ITCC-082: a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.
    Future oncology (London, England), 2021, Volume: 17, Issue:32

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Etoposide; Humans; Ifosfamide; Middle Aged; Osteosarcoma; Phenylurea Compounds; Protein Kinase Inhibitors; Quality of Life; Quinolines; Young Adult

2021
Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.
    JAMA oncology, 2017, Sep-01, Volume: 3, Issue:9

    Topics: Administration, Metronomic; Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Celecoxib; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasms; Response Elements; Retreatment; Sarcoma, Ewing; Survival Rate; Thalidomide; Time Factors

2017
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.
    European journal of cancer (Oxford, England : 1990), 2018, Volume: 88

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Diphosphonates; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Imidazoles; Kaplan-Meier Estimate; Male; Methotrexate; Neutropenia; Osteosarcoma; Young Adult; Zoledronic Acid

2018
Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
    The Gulf journal of oncology, 2019, Volume: 1, Issue:30

    Topics: Administration, Metronomic; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Sarcoma, Ewing; Survival Rate; Tamoxifen; Young Adult

2019
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
    International journal of cancer, 2020, 01-15, Volume: 146, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; France; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Prognosis; Survival Rate; Young Adult; Zoledronic Acid

2020
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age.
    Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Male; Melphalan; Mesna; Neoplasm Staging; Prognosis; Prospective Studies; Sarcoma, Ewing; Sex Factors; Survival Rate; Vincristine; Young Adult

2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Aug-10, Volume: 32, Issue:23

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Sarcoma, Ewing; Treatment Outcome; Vincristine; Young Adult

2014
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Polyethylene Glycols; Quality of Life; Research Design; Young Adult

2015
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:22

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Extremities; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate

2014
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Proportional Hazards Models; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine

2015
Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
    Journal of surgical oncology, 2015, Volume: 112, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate

2015
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Sarcoma, Ewing; Vincristine

2008
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, May-20, Volume: 27, Issue:15

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine

2009
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
    Cancer, 2009, Jul-01, Volume: 115, Issue:13

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma

2009
Results of RS-99 protocol for childhood solid tumors.
    World journal of pediatrics : WJP, 2010, Volume: 6, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Sarcoma, Ewing; Tamoxifen; Vincristine

2010
[Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
    Voprosy onkologii, 2010, Volume: 56, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Follow-Up Studies; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome; Young Adult

2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult

2011
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-20, Volume: 30, Issue:33

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Middle Aged; Prospective Studies; Sarcoma, Ewing; Vincristine; Young Adult

2012
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Recurrence; Sarcoma, Ewing

2013
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    The New England journal of medicine, 2003, Feb-20, Volume: 348, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine

2003
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer.
    International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:7

    Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dexamethasone; Drug Administration Schedule; Epirubicin; Etoposide; Hormone Antagonists; Humans; Male; Middle Aged; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome

2003
Unstratified chemotherapy for non-metastatic osteosarcoma of the extremities in children.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2003, Volume: 102, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Statistics, Nonparametric; Survival Analysis; Taiwan; Treatment Outcome

2003
Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-15, Volume: 21, Issue:18

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prospective Studies; Recurrence; Remission Induction; Sarcoma, Ewing; Vincristine

2003
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study.
    Urology, 2004, Volume: 63, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Dexamethasone; Diabetes Mellitus; Disease-Free Survival; Estramustine; Etoposide; Gastrointestinal Diseases; Gonadotropin-Releasing Hormone; Hematologic Diseases; Humans; Life Tables; Male; Middle Aged; Orchiectomy; Peptides, Cyclic; Prostatic Neoplasms; Somatostatin; Survival Analysis; Treatment Outcome; Triptorelin Pamoate

2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jul-15, Volume: 22, Issue:14

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine

2004
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cohort Studies; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitoxantrone; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation, Autologous; Treatment Outcome

2005
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Survival Analysis

2005
A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.
    Pediatric blood & cancer, 2006, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Osteosarcoma

2006
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experie
    Cancer, 2006, Apr-15, Volume: 106, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Vincristine

2006
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Cancer, 2006, Apr-15, Volume: 106, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Vincristine

2006
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-20, Volume: 24, Issue:24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine

2006
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
    Blood, 2007, Jan-01, Volume: 109, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine

2007
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients.
    European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Preoperative Care

2007
Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma.
    Clinical genitourinary cancer, 2007, Volume: 5, Issue:5

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease Progression; Estramustine; Etoposide; Feasibility Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms, Hormone-Dependent; Paclitaxel; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Treatment Outcome

2007
A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Kidney Neoplasms; Melphalan; Neoplasms; Neuroblastoma; Pilot Projects; Recurrence; Risk Factors; Sarcoma; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Wilms Tumor

2008
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:10

    Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Estramustine; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Survival Rate

1994
Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
    British journal of cancer, 1995, Volume: 71, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Prognosis; Survival Rate; Testicular Neoplasms; Time Factors; Vinblastine

1995
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:10

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Heart Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Mitoxantrone; Neutropenia; Pilot Projects; Platelet Count; Remission Induction; Survival Rate; Vincristine

1995
Salvage chemotherapy for recurrent Ewing's sarcomas.
    Neoplasma, 1995, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Salvage Therapy; Sarcoma, Ewing; Treatment Outcome

1995
Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
    British journal of cancer, 1995, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasms; Neuroblastoma; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Rhabdomyosarcoma; Sarcoma, Ewing; Verapamil; Wilms Tumor

1995
Treatment of advanced hormone-refractory prostate carcinoma with a combination of etoposide, pirarubicin and cisplatin.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:3

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Drug Resistance; Estrogens; Etoposide; Gonadotropin-Releasing Hormone; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Treatment Outcome

1995
An update of Scandinavian studies of osteosarcoma.
    Cancer treatment and research, 1993, Volume: 62

    Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome

1993
Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
    Cancer treatment and research, 1993, Volume: 62

    Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Florida; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Life Tables; Lung Neoplasms; Methotrexate; Osteosarcoma; Survival Analysis; Treatment Outcome

1993
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
    Journal of chemotherapy (Florence, Italy), 1993, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine

1993
Phase II trial of carboplatin and etoposide in metastatic breast cancer.
    Cancer, 1993, Feb-15, Volume: 71, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Etoposide; Female; Humans; Injections, Intravenous; Liver; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Remission Induction; Survival Rate

1993
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
    Cancer, 1996, Aug-15, Volume: 78, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Heart Failure; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine

1996
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Middle Aged; Palliative Care; Pneumonectomy; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Treatment Outcome

1997
Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Female; Humans; Ifosfamide; Male; Osteosarcoma; Survival Rate; Treatment Outcome

1997
Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer.
    American journal of clinical oncology, 1997, Volume: 20, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease Progression; Drug Administration Schedule; Estramustine; Etoposide; Humans; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Vinblastine; Vinorelbine

1997
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
    Cancer, 1998, Mar-15, Volume: 82, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine

1998
Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
    Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Epirubicin; Etoposide; Extremities; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis

1998
Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

    Topics: Adolescent; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Neoplasms; Capillary Leak Syndrome; Combined Modality Therapy; Cytokines; Drug Synergism; Etoposide; Feasibility Studies; Female; Femoral Neoplasms; Fever; Fibrosis; Gastrointestinal Diseases; Humans; Hypotension; Immunologic Factors; Interleukin-1; Lung Neoplasms; Male; Neutropenia; Osteosarcoma; Recombinant Proteins; Remission Induction; Respiration Disorders; Salvage Therapy; Treatment Outcome

1997
Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.
    Journal of cancer research and clinical oncology, 1998, Volume: 124, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Methotrexate; Middle Aged; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Predictive Value of Tests; Prognosis; Tomography, X-Ray Computed

1998
Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
    International journal of radiation oncology, biology, physics, 1998, Dec-01, Volume: 42, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Thorax; Vincristine

1998
[CBDCA, etoposide and epirubicin high-dose combination chemotherapy supported by peripheral blood stem cell transplantation (PBSCT) in metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local

1999
Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy.
    Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Etoposide; Female; Humans; Interferon-gamma; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine

1999
Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Rate

1999
Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Resistance, Neoplasm; Estramustine; Etoposide; Humans; Male; Middle Aged; Paclitaxel; Prostatic Neoplasms; Quality of Life; Soft Tissue Neoplasms; Survival Rate; Treatment Outcome

1999
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
    Bone marrow transplantation, 2000, Volume: 25, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Middle Aged; Mitoxantrone; Platelet Count; Soft Tissue Neoplasms; Survival Rate; Tamoxifen; Thiotepa; Transplantation, Autologous

2000
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Dec-15, Volume: 18, Issue:24

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Extremities; Female; Fertility; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteosarcoma; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Radiography; Reoperation; Survival Rate

2000
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-01, Volume: 19, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation

2001
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:1

    Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Diphosphonates; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Incidence; Infant; Iodine Radioisotopes; Kidney Diseases; Male; Neoplasm Staging; Nervous System Diseases; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Survival Analysis; Survival Rate; Technetium Compounds; Treatment Outcome; Vincristine

2001
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-15, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Thrombocytopenia; Treatment Outcome

2002
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine

2001
High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Apr-15, Volume: 20, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Remission Induction; Survival Analysis; Transplantation, Autologous

2002
Effect of chemotherapy combined with caffeine for osteosarcoma.
    Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Calcaneus; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Infusions, Intra-Arterial; Male; Methotrexate; Osteosarcoma; Salvage Therapy; Tibia

1992
Treatment of small cell lung cancer: experience at Maharaj Nakhon Chiang Mai Hospital.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1991, Volume: 74, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Thailand; Vincristine

1991
Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue.
    Bone marrow transplantation, 1991, Volume: 7 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Combined Modality Therapy; Etoposide; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Melphalan; Radiotherapy Dosage; Remission Induction; Sarcoma, Ewing; Survival Rate; Whole-Body Irradiation

1991
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Brain Neoplasms; Chorionic Gonadotropin; Cisplatin; Creatinine; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Remission Induction; Survival Analysis; Vincristine

1991

Other Studies

189 other study(ies) available for etoposide and Bone Cancer

ArticleYear
Intensive Multimodal Therapy Combined With Long-term Temozolomide and Etoposide Treatment for Recurrent Osteosarcoma to the Liver and Stomach.
    Journal of pediatric hematology/oncology, 2022, 05-01, Volume: 44, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Etoposide; Humans; Liver; Neoplasm Recurrence, Local; Osteosarcoma; Stomach; Temozolomide

2022
Deficiency of TRDMT1 impairs exogenous RNA-based response and promotes retrotransposon activity during long-term culture of osteosarcoma cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2022, Volume: 80

    Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA (Cytosine-5-)-Methyltransferases; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Osteosarcoma; Retroelements; RNA

2022
Outcomes of Pediatric Patients With Metastatic Ewing Sarcoma Treated With Interval Compression.
    Journal of pediatric hematology/oncology, 2023, 04-01, Volume: 45, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasms, Second Primary; Sarcoma, Ewing; Vincristine

2023
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma.
    Pediatric hematology and oncology, 2023, Volume: 40, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Enzyme Therapy; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine

2023
Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver Disease.
    Journal of pediatric hematology/oncology, 2023, Jul-01, Volume: 45, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cholestasis; Cholestasis, Intrahepatic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine

2023
The effectiveness and mechanical properties of chemotherapy-impregnated cement in Ewing sarcoma.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2023, Volume: 41, Issue:11

    Topics: Antineoplastic Agents; Bone Cements; Bone Neoplasms; Doxorubicin; Etoposide; Humans; Sarcoma, Ewing

2023
Treatment outcomes of extraskeletal Ewing sarcoma.
    Journal of surgical oncology, 2023, Volume: 128, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Male; Sarcoma; Sarcoma, Ewing; Treatment Outcome; Vincristine

2023
[A Case of Testicular Cancer with Solitary Iliac Bone Metastasis].
    Hinyokika kiyo. Acta urologica Japonica, 2023, Volume: 69, Issue:9

    Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Young Adult

2023
Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020, Volume: 22, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Recurrence, Local; Retrospective Studies; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine

2020
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines.
    PloS one, 2019, Volume: 14, Issue:9

    Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cyclophosphamide; Depsipeptides; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Etoposide; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone Demethylases; Humans; Hydrazines; Irinotecan; Sarcoma, Ewing; Sulfonamides; Vincristine

2019
Interaction of arsenic trioxide and etoposide in Ewing sarcoma cell lines.
    Oncology reports, 2020, Volume: 43, Issue:1

    Topics: Arsenic Trioxide; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Multidrug Resistance-Associated Proteins; Phosphorylation; Sarcoma, Ewing; Zinc Finger Protein GLI1

2020
Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience.
    BMC cancer, 2019, Dec-02, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2019
Hemophagocytic relapsed intramedullary plasmacytoma.
    International journal of hematology, 2020, Volume: 111, Issue:6

    Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Bortezomib; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Melphalan; Neoplasm Recurrence, Local; Oligopeptides; Plasmacytoma; Positron Emission Tomography Computed Tomography; Pubic Bone; Rare Diseases; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Treatment Outcome

2020
Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
    The oncologist, 2020, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Humans; Ifosfamide; Middle Aged; Retrospective Studies; Sarcoma; Vincristine; Young Adult

2020
Temozolomide and etoposide combination for the treatment of relapsed osteosarcoma.
    Japanese journal of clinical oncology, 2020, Aug-04, Volume: 50, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Temozolomide; Young Adult

2020
Challenges in the management of localized Ewing sarcoma in a developing country.
    Pediatric hematology and oncology, 2020, Volume: 37, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Developing Countries; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Patient Compliance; Prognosis; Retrospective Studies; Sarcoma, Ewing; Sepsis; Survival Rate; Vincristine

2020
Efficacy and safety of oral metronomic etoposide in adult patients with metastatic osteosarcoma.
    Cancer medicine, 2021, Volume: 10, Issue:1

    Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Osteosarcoma; Progression-Free Survival; Retrospective Studies; Time Factors; Young Adult

2021
Temporal modulation of the NF-κB RelA network in response to different types of DNA damage.
    The Biochemical journal, 2021, 02-12, Volume: 478, Issue:3

    Topics: Amino Acid Motifs; Amino Acid Sequence; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Chromatography, Liquid; Consensus Sequence; DNA Breaks, Double-Stranded; DNA Damage; DNA Replication; DNA, Neoplasm; Etoposide; Humans; Hydroxyurea; Osteosarcoma; Phosphorylation; Protein Interaction Maps; Protein Kinases; Protein Processing, Post-Translational; Proteomics; Tandem Mass Spectrometry; Time Factors; Transcription Factor RelA

2021
A Case of Ewing Sarcoma of the Bladder Presenting in Early Infancy.
    Journal of pediatric hematology/oncology, 2021, 05-01, Volume: 43, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematuria; Humans; Ifosfamide; Infant; Sarcoma, Ewing; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine

2021
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing country.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Developing Countries; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult

2021
Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatment.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:11

    Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Humans; Neoplasms, Germ Cell and Embryonal; Osteosarcoma; Palliative Care; Young Adult

2021
Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath.
    World neurosurgery, 2017, Volume: 104

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Etoposide; Female; Femoral Nerve; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Nerve Sheath Neoplasms; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2017
Consideration of alternative causes of lactic acidosis: Thiamine deficiency in malignancy.
    The American journal of emergency medicine, 2017, Volume: 35, Issue:8

    Topics: Acidosis, Lactic; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Confusion; Etoposide; Humans; Male; Psychomotor Agitation; Small Cell Lung Carcinoma; Thiamine; Thiamine Deficiency; Treatment Outcome; Vitamin B Complex

2017
Burned-out seminoma revealed by solitary rib bone metastasis.
    Skeletal radiology, 2017, Volume: 46, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Contrast Media; Diagnosis, Differential; Etoposide; Humans; Magnetic Resonance Imaging; Male; Orchiectomy; Ribs; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed

2017
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.
    International journal of radiation oncology, biology, physics, 2017, 12-01, Volume: 99, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Etoposide; Extremities; Humans; Ifosfamide; Infant; Middle Aged; Neoplasm Recurrence, Local; Pelvic Bones; Retrospective Studies; Sarcoma, Ewing; Treatment Failure

2017
Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models.
    Archives of toxicology, 2018, Volume: 92, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Cyclin E; Etoposide; Flavonoids; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Oncogene Proteins; Osteosarcoma; Tumor Stem Cell Assay

2018
Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.
    Medicine, 2017, Volume: 96, Issue:51

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Endostatins; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Osteosarcoma; Pleural Effusion, Malignant; Recombinant Proteins

2017
Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.
    BMJ case reports, 2018, Mar-16, Volume: 2018

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Rituximab; Vincristine

2018
Paclitaxel and etoposide-loaded Poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery.
    Journal of biomaterials science. Polymer edition, 2018, Volume: 29, Issue:16

    Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Interactions; Drug Liberation; Etoposide; Humans; Microspheres; Paclitaxel; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer

2018
Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.
    International orthopaedics, 2019, Volume: 43, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Case-Control Studies; Cementation; Child; Child, Preschool; Combined Modality Therapy; Curettage; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Phenol; Recovery of Function; Retrospective Studies; Sarcoma, Ewing; Sclerosing Solutions; Sclerotherapy; Wound Healing

2019
Solitary Bone Metastasis as the First Presentation of Germ Cell Testicular Cancer Treated with Internal Hemipelvectomy: A Case Report.
    Urologia internationalis, 2019, Volume: 103, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Neoplasms; Cisplatin; Etoposide; Hemipelvectomy; Humans; Male; Neoplasm Metastasis; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Pelvic Bones; Testicular Neoplasms; Treatment Outcome

2019
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:1

    Topics: Adolescent; Bone Neoplasms; Drug Hypersensitivity; Etoposide; Humans; Male; Organophosphorus Compounds; Osteosarcoma; Sarcoma, Ewing

2020
ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
    Cancer letters, 2019, 07-01, Volume: 453

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; HEK293 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Neoplastic Stem Cells; Osteosarcoma; RNA, Messenger; Vincristine

2019
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
    Journal of global oncology, 2019, Volume: 5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Lebanon; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Retrospective Studies; Risk Assessment; Treatment Outcome

2019
Osteosarcoma journey over two decades in India: Small steps, big changes.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; India; Male; Middle Aged; Osteosarcoma; Survival Rate

2019
YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells.
    The Journal of veterinary medical science, 2019, Aug-24, Volume: 81, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Dog Diseases; Dogs; Drug Synergism; Etoposide; Humans; Imidazoles; Mice; Naphthoquinones; Osteosarcoma; Survivin; Xenograft Model Antitumor Assays

2019
Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report.
    World journal of surgical oncology, 2013, Feb-26, Volume: 11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Gastrectomy; Hematemesis; Humans; Ifosfamide; Male; Neoplasm Staging; Osteosarcoma; Prognosis; Stomach Neoplasms

2013
Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.
    Cancer research, 2013, Jul-01, Volume: 73, Issue:13

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Coculture Techniques; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Melphalan; Membrane Potential, Mitochondrial; Mesenchymal Stem Cells; Monocytes; Neuroblastoma; Receptors, Interleukin-6; STAT3 Transcription Factor; Up-Regulation

2013
Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
    World journal of surgical oncology, 2013, Jun-05, Volume: 11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Review Literature as Topic

2013
Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
    American journal of clinical oncology, 2015, Volume: 38, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Mediastinal Neoplasms; Middle Aged; Neuroectodermal Tumors, Primitive, Peripheral; Pleural Neoplasms; Retroperitoneal Neoplasms; Retrospective Studies; Teratoma; Testicular Neoplasms; Treatment Outcome; Vincristine; Young Adult

2015
[Hypersensitivity reaction to etoposide. A case report].
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, May-01, Volume: 38, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Drug Hypersensitivity; Etoposide; Femur; Humans; Male; Sarcoma, Ewing

2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
    Pediatric blood & cancer, 2015, Volume: 62, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Salvage Therapy; Sarcoma, Ewing; Survival Rate; Young Adult

2015
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Daunorubicin; Etoposide; Fluorouracil; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Integrin alphaVbeta3; Membrane Transport Modulators; Methotrexate; Osteopontin; Osteosarcoma; Phloretin; Up-Regulation

2014
p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    PloS one, 2014, Volume: 9, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Proliferation; Chromatin Immunoprecipitation; DNA Damage; DNA Methylation; Etoposide; Gene Expression Regulation, Neoplastic; Genes, Dominant; Humans; MicroRNAs; Molecular Sequence Data; Mutation; Osteosarcoma; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2014
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
    Journal of surgical oncology, 2015, Volume: 111, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukocyte Count; Male; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine

2015
Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    International journal of radiation oncology, biology, physics, 2015, May-01, Volume: 92, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cause of Death; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Proportional Hazards Models; Radiotherapy Dosage; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult

2015
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma.
    Journal of nanobiotechnology, 2015, Mar-21, Volume: 13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Carriers; Etoposide; Humans; Lactic Acid; Nanoparticles; Osteosarcoma; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer

2015
Nanoemulsion based concomitant delivery of curcumin and etoposide: impact on cross talk between prostate cancer cells and osteoblast during metastasis.
    Journal of biomedical nanotechnology, 2014, Volume: 10, Issue:11

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Communication; Cell Line, Tumor; Curcumin; Drug Combinations; Emulsions; Etoposide; Humans; Male; Mice; Nanocapsules; Osteoblasts; Prostatic Neoplasms; Rats, Sprague-Dawley; Treatment Outcome

2014
Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines.
    Anti-cancer drugs, 2015, Volume: 26, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Sarcoma, Ewing; Vorinostat

2015
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
    Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Caspases; Cell Proliferation; Etoposide; Flow Cytometry; Heterocyclic Compounds, 4 or More Rings; Humans; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Ewing; Sirtuin 1; Stilbenes; Tumor Cells, Cultured; Vincristine

2016
YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.
    Molecular cancer research : MCR, 2015, Volume: 13, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Cell Line, Tumor; Circular Dichroism; Colorectal Neoplasms; DNA Breaks, Double-Stranded; DNA Repair; Drug Synergism; Etoposide; Glioma; High-Throughput Screening Assays; Humans; Intercalating Agents; Mice; Mice, Nude; Molecular Structure; Neoplasms; Osteosarcoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiation-Sensitizing Agents; Small Molecule Libraries; Sulfonamides; Xenograft Model Antitumor Assays

2015
Identification of Discrete Prognostic Groups in Ewing Sarcoma.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Age Factors; Bone Neoplasms; Child; Child, Preschool; Databases, Factual; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Sarcoma, Ewing; SEER Program

2016
Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
    Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Substitution; Etoposide; Female; Follow-Up Studies; Hearing Loss; Humans; Ifosfamide; Kidney Diseases; Leucovorin; Male; Methotrexate; Osteosarcoma; Pilot Projects; Stroke Volume; Survival Rate; Treatment Outcome; Young Adult

2015
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cardiotonic Agents; Child; Child, Preschool; Cisplatin; Dexrazoxane; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Methotrexate; Osteosarcoma; Treatment Outcome; Ventricular Dysfunction

2016
Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.
    Oncotarget, 2015, Oct-13, Volume: 6, Issue:31

    Topics: Alternative Splicing; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DEAD-box RNA Helicases; DNA Damage; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Oncogene Proteins, Fusion; Phosphorylation; Proto-Oncogene Protein c-fli-1; RNA Polymerase II; RNA Precursors; RNA-Binding Protein EWS; RNA, Messenger; Sarcoma, Ewing; Signal Transduction; Time Factors; Topoisomerase II Inhibitors; Transfection; Ultraviolet Rays

2015
Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Topotecan; Vincristine

2016
Ewing Sarcoma: A 15-Year Experience of a Single Center With the MSKCC P6 Treatment Protocol.
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Prognosis; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; Vincristine

2016
Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
    International journal of oncology, 2016, Volume: 49, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Bone Neoplasms; Drug Synergism; Etoposide; Flow Cytometry; Humans; Oxides; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; Tumor Cells, Cultured

2016
Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
    Veterinary journal (London, England : 1997), 2016, Volume: 218

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dog Diseases; Dogs; Down-Regulation; Etoposide; Osteosarcoma; Piroxicam; Up-Regulation

2016
Anaplastic large cell lymphoma masquerading as osteomyelitis of the shoulder: an uncommon presentation.
    BMJ case reports, 2016, Dec-21, Volume: 2016

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Lymphatic Metastasis; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Osteomyelitis; Positron Emission Tomography Computed Tomography; Prednisone; Shoulder; Skin Neoplasms; Vincristine

2016
Hesperetin-etoposide combinations induce cytotoxicity in U2OS cells: Implications on therapeutic developments for osteosarcoma.
    DNA repair, 2017, Volume: 50

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cytotoxins; Doxorubicin; Etoposide; Hesperidin; Humans; Osteosarcoma

2017
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Osteosarcoma; Pneumonectomy; Prognosis; Retrospective Studies; Salvage Therapy; Survival Analysis

2008
WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
    DNA repair, 2008, Dec-01, Volume: 7, Issue:12

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Bone Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Survival; Colony-Forming Units Assay; DNA Breaks; DNA Repair; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Enzyme Inhibitors; Etoposide; Exodeoxyribonucleases; Histones; Humans; Osteosarcoma; RecQ Helicases; RNA, Small Interfering; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured; Werner Syndrome Helicase

2008
Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
    Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Remission Induction; Sarcoma, Ewing; Treatment Outcome; Young Adult

2009
Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2009, Volume: 14, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Male; Muscle Neoplasms; Pain; Pamidronate; Sarcoma, Synovial; Vincristine

2009
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
    Journal of surgical oncology, 2009, Sep-01, Volume: 100, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine

2009
Caffeine-potentiated chemotherapy for metastatic osteosarcoma.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2009, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Child; Cisplatin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Osteosarcoma; Young Adult

2009
Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Teratoma; Treatment Outcome; Vincristine; Young Adult

2010
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6

    Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune

2010
Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
    Archives of medical research, 2010, Volume: 41, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Cisplatin; Combined Modality Therapy; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Genetic Therapy; Humans; Inhibitor of Apoptosis Proteins; Membrane Potential, Mitochondrial; Microtubule-Associated Proteins; Osteosarcoma; RNA, Small Interfering; Survivin

2010
Chest wall Ewing sarcoma family of tumors: long-term outcomes.
    International journal of radiation oncology, biology, physics, 2011, Sep-01, Volume: 81, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Recurrence, Local; Radiotherapy Dosage; Sarcoma, Ewing; Thoracic Wall; Time Factors; Vincristine; Young Adult

2011
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Floxuridine; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult

2011
Neuroblastoma in an adult: case report.
    Revista medica de Chile, 2010, Volume: 138, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neuroblastoma; Spinal Cord Compression; Spinal Cord Neoplasms; Thoracic Vertebrae; Vincristine; Young Adult

2010
Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
    Oncology reports, 2011, Volume: 25, Issue:4

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Bone Neoplasms; Child; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Oligonucleotides; Osteosarcoma; Rhabdomyosarcoma; Sarcoma, Ewing; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; X-Linked Inhibitor of Apoptosis Protein

2011
Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate.
    International journal of clinical oncology, 2011, Volume: 16, Issue:6

    Topics: Adenocarcinoma; Androgen Antagonists; Bone Neoplasms; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Remission Induction

2011
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:6

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult

2011
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma.
    Acta haematologica, 2011, Volume: 126, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dioxoles; Etoposide; Fatal Outcome; Female; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Sarcoma, Ewing; Tetrahydroisoquinolines; Topoisomerase Inhibitors; Trabectedin; Young Adult

2011
Unusual seminoma revealed by bone metastasis.
    Joint bone spine, 2011, Volume: 78, Issue:6

    Topics: Bone Neoplasms; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Seminoma; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2011
The effects of chemotherapeutic agents on differentiated chordoma cells.
    Journal of neurosurgery. Spine, 2011, Volume: 15, Issue:6

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Chordoma; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Imatinib Mesylate; Methotrexate; Piperazines; Pyrimidines; Vidarabine; Vincristine

2011
Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Brain Neoplasms; Camptothecin; Carboplatin; Cisplatin; DNA-Binding Proteins; Endonucleases; Etoposide; Female; Follow-Up Studies; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoenzyme Techniques; Irinotecan; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate

2012
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
    Chinese journal of cancer, 2012, Volume: 31, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine; Young Adult

2012
EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.
    Molecular cancer research : MCR, 2012, Volume: 10, Issue:8

    Topics: Bone Neoplasms; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Mesenchymal Stem Cells; MicroRNAs; Oncogene Proteins, Fusion; Protein Tyrosine Phosphatases; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; Sarcoma, Ewing

2012
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Melphalan; Myeloablative Agonists; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Stem Cell Transplantation; Vincristine; Young Adult

2012
[Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Transplantation; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Orthopedic Procedures; Osteosarcoma; Transplantation, Autologous; Treatment Outcome

2012
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
    Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Female; Hamartoma; Humans; Ifosfamide; Liver Neoplasms; Mesoderm; Prognosis; Sarcoma, Ewing; Vincristine; Young Adult

2013
Synergistic increase in the sensitivity of osteosarcoma cells to thermochemotherapy with combination of paclitaxel and etoposide.
    Molecular medicine reports, 2012, Volume: 6, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Therapy, Combination; Etoposide; fas Receptor; Humans; Osteosarcoma; Paclitaxel; Temperature

2012
Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cryopreservation; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fertility Preservation; Follicle Stimulating Hormone; Humans; Ifosfamide; Ovary; Primary Ovarian Insufficiency; Prognosis; Puberty; Radiotherapy, Conformal; Sarcoma, Ewing; Vincristine

2013
Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013, Volume: 34, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Blotting, Western; Bone Neoplasms; Caspases; Cells, Cultured; Doxorubicin; Etoposide; Fibroblasts; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Luciferases; Osteosarcoma; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shelterin Complex; Telomere-Binding Proteins; Telomeric Repeat Binding Protein 1; Topoisomerase II Inhibitors

2013
The Poly(ADP-ribose) polymerase-1-regulated endonuclease DNAS1L3 is required for etoposide-induced internucleosomal DNA fragmentation and increases etoposide cytotoxicity in transfected osteosarcoma cells.
    Cancer research, 2002, Aug-01, Volume: 62, Issue:15

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Bone Neoplasms; Calcium; Caspase 3; Caspases; DNA Fragmentation; Endodeoxyribonucleases; Enzyme Activation; Etoposide; Humans; Nucleosomes; Osteosarcoma; Poly(ADP-ribose) Polymerases; Proteins; Recombinant Proteins; Staurosporine; Transfection; Tumor Cells, Cultured

2002
High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2002, Volume: 7, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Sarcoma, Ewing; Survival Rate; Treatment Outcome

2002
Excellent long-term survival in patients with early-stage primary bone lymphoma treated with doxorubicin-based chemotherapy and local radiotherapy.
    American journal of clinical oncology, 2002, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Vincristine

2002
Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:3

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cisplatin; Etoposide; Fluid Therapy; Humans; Liver Neoplasms; Male; Medulloblastoma; Renal Dialysis; Tumor Lysis Syndrome

2003
Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant, Newborn; Italy; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Oligospermia; Osteosarcoma; Puberty; Semen Preservation; Sperm Count; Surveys and Questionnaires

2003
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
    Head & neck, 2003, Volume: 25, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis

2003
E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
    Cancer research, 2003, Jun-15, Volume: 63, Issue:12

    Topics: Adenovirus E1A Proteins; Adenoviruses, Human; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Etoposide; Female; Fibrosarcoma; Genes, p53; Humans; Immunologic Surveillance; Kidney; Killer Cells, Natural; Mice; Mice, Nude; Oncogenes; Osteosarcoma; Rats; Rats, Nude; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2003
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-15, Volume: 21, Issue:16

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Sarcoma, Ewing; Survival Analysis; Whole-Body Irradiation

2003
Ileoileal intussusception caused by a Ewing sarcoma tumour. An unusual case report.
    European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2003, Volume: 13, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Digestive System Surgical Procedures; Doxorubicin; Etoposide; Humans; Ifosfamide; Ileal Diseases; Ileal Neoplasms; Intussusception; Male; Sarcoma, Ewing; Stem Cell Transplantation; Treatment Outcome; Vincristine

2003
Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis.
    Bone, 2003, Volume: 33, Issue:2

    Topics: Anoikis; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Caspases; Cell Adhesion; Cell Division; Cell Line, Tumor; Cholesterol; Diphosphonates; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Imidazoles; Osteosarcoma; Zoledronic Acid

2003
Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Nov-01, Volume: 9, Issue:14

    Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Carcinoma, Small Cell; Cell Division; Diphosphonates; Drug Combinations; Etoposide; Humans; Imidazoles; Kidney Neoplasms; Killer Cells, Natural; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred ICR; Mice, SCID; Osteoclasts; Parathyroid Hormone-Related Protein; Survival Rate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2003
Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
    Onkologie, 2003, Volume: 26, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retreatment; Sarcoma, Ewing

2003
[p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide].
    Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; DNA-Binding Proteins; Drug Synergism; Etoposide; Genes, Tumor Suppressor; Humans; Inhibitor of Growth Protein 1; Intracellular Signaling Peptides and Proteins; Nuclear Proteins; Osteosarcoma; Proteins; Transfection; Tumor Suppressor Proteins

2004
[Neoadjuvant chemotherapy for osteosarcoma].
    Zhonghua yi xue za zhi, 2004, Jul-17, Volume: 84, Issue:14

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Drug Administration Schedule; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Osteosarcoma; Retrospective Studies

2004
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
    International journal of radiation oncology, biology, physics, 2004, Nov-01, Volume: 60, Issue:3

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine

2004
Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
    Urology, 2004, Volume: 64, Issue:4

    Topics: Abdominal Pain; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dexamethasone; Etoposide; Female; Fetus; Humans; Ifosfamide; Infant, Newborn; Kidney Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Neoplasm Recurrence, Local; Patient Dropouts; Polyradiculopathy; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Spinal Cord Compression; Vincristine; Wilms Tumor

2004
VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
    American journal of clinical oncology, 2004, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Salvage Therapy; Sarcoma, Ewing; Survival Analysis

2004
Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
    Japanese journal of clinical oncology, 2004, Volume: 34, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Vincristine

2004
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lumbar Vertebrae; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Thoracic Vertebrae; Time Factors; Tomography, X-Ray Computed

2005
Role of heat treatment in childhood cancers: distinct resistance profiles of solid tumor cell lines towards combined thermochemotherapy.
    Pediatric blood & cancer, 2005, Oct-15, Volume: 45, Issue:5

    Topics: Antineoplastic Agents; Bone Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Child; Cisplatin; Combined Modality Therapy; Cross-Linking Reagents; Etoposide; Humans; Hyperthermia, Induced; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Topoisomerase II Inhibitors

2005
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
    International journal of radiation oncology, biology, physics, 2006, Feb-01, Volume: 64, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2006
Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Cancer gene therapy, 2006, Volume: 13, Issue:4

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Genetic Therapy; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondrial Proteins; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Transfection; Tumor Suppressor Protein p53

2006
The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells.
    Life sciences, 2006, Feb-23, Volume: 78, Issue:13

    Topics: Apoptosis; Bone Neoplasms; Cell Division; Cell Line, Tumor; Etoposide; Humans; Inhibitor of Growth Protein 1; Intracellular Signaling Peptides and Proteins; Nuclear Proteins; Osteosarcoma; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2006
Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations.
    The Journal of clinical investigation, 2006, Volume: 116, Issue:1

    Topics: Bone Neoplasms; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Chromosome Aberrations; Chromosome Banding; Chromosomes, Human, Pair 11; Cloning, Molecular; Etoposide; G2 Phase; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Humans; Myeloid-Lymphoid Leukemia Protein; Osteosarcoma; Translocation, Genetic

2006
[A case of primary and solitary bone metastasis of testicular seminoma after orchiectomy].
    Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Orchiectomy; Peplomycin; Positron-Emission Tomography; Seminoma; Testicular Neoplasms

2005
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.
    Pediatric blood & cancer, 2006, Volume: 47, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Statistics, Nonparametric; Vincristine

2006
Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; United States; Vincristine

2007
High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Busulfan; Combined Modality Therapy; Disease Progression; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Recurrence, Local; Sarcoma, Ewing; Treatment Outcome

2006
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Jun-15, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Child; Etoposide; Female; Follow-Up Studies; Humans; Male; Osteosarcoma; Oxides; Paclitaxel; Sarcoma, Ewing; Treatment Outcome

2006
[Acquired Fanconi-de Toni-Debre syndrome due to therapy for Ewing's sarcoma in 5-years old boy].
    Przeglad lekarski, 2006, Volume: 63 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Dactinomycin; Doxorubicin; Etoposide; Fanconi Syndrome; Femur; Humans; Ifosfamide; Male; Sarcoma, Ewing; Vincristine

2006
[Lung cancer with bone metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:8

    Topics: Analgesics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Diphosphonates; Docetaxel; Drug Administration Schedule; Etoposide; Fractures, Bone; Gefitinib; Humans; Irinotecan; Lung Neoplasms; Paclitaxel; Pain, Intractable; Prognosis; Quinazolines; Radiotherapy Dosage; Taxoids

2006
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:11

    Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Particle Accelerators; Radioisotope Teletherapy; Radiotherapy, Conformal; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis

2006
Juvenile Ewing sarcoma presenting as a pelvic mass.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2007, Volume: 17, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Sarcoma, Ewing

2007
Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan: the Japanese Musculoskeletal Oncology Group cooperative study.
    Cancer, 2007, Feb-15, Volume: 109, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Male; Middle Aged; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome

2007
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine

2007
Identification of uPAR-positive chemoresistant cells in small cell lung cancer.
    PloS one, 2007, Feb-28, Volume: 2, Issue:2

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Brain Neoplasms; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Fluorouracil; Humans; Hyaluronan Receptors; Lung Neoplasms; Neoplasm Proteins; Neoplastic Stem Cells; Phenotype; Receptors, Urokinase Plasminogen Activator; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urokinase-Type Plasminogen Activator

2007
Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Pelvic Bones; Peripheral Blood Stem Cell Transplantation; Remission Induction; Risk; Sarcoma, Ewing; Scapula; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine

2007
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
    The Netherlands journal of medicine, 2007, Volume: 65, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Netherlands; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine

2007
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate

2007
Prognostic factors for local and distant control in Ewing sarcoma family of tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Dose Fractionation, Radiation; Etoposide; Female; Humans; Ifosfamide; Incidence; Infant; Male; Medical Records; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Treatment Failure

2008
Expression of androgen receptor is negatively regulated by p53.
    Neoplasia (New York, N.Y.), 2007, Volume: 9, Issue:12

    Topics: 5' Untranslated Regions; Adenocarcinoma; Androgens; Bone Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Consensus Sequence; DNA, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Male; Neoplasms, Hormone-Dependent; Osteosarcoma; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Transfection; Tumor Suppressor Protein p53

2007
Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
    Life sciences, 2008, Feb-13, Volume: 82, Issue:7-8

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Combinations; Etoposide; Humans; Interferon-alpha; Mutation; Osteosarcoma; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53

2008
Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Medical Records; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate

2008
Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Oct-24, Volume: 92, Issue:22

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Base Sequence; Bone Neoplasms; Cell Division; Cell Line; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fibrosarcoma; Floxuridine; Humans; Liposarcoma; Methotrexate; Molecular Sequence Data; Oligonucleotide Probes; Osteosarcoma; Recombinant Proteins; Retinoblastoma Protein; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Transfection; Tumor Cells, Cultured

1995
Calla positive acute lymphoblastic leukemia after etoposide-based therapy for Ewing's sarcoma.
    Leukemia research, 1995, Volume: 19, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Humans; Male; Neoplasms, Second Primary; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Ewing; Tibia

1995
Metastatic adamantinoma of bone to lung. A case report of the natural history and the use of chemotherapy and radiation therapy.
    American journal of clinical oncology, 1994, Volume: 17, Issue:2

    Topics: Ameloblastoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Postoperative Care; Radiotherapy Dosage; Tibia

1994
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
    Journal of neuro-oncology, 1994, Volume: 21, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine

1994
[A case of complete response with radiation and chemotherapy using cisplatin, etoposide and bleomycin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Humans; Lymphatic Metastasis; Male; Orchiectomy; Radiotherapy Dosage; Remission Induction; Testicular Neoplasms

1993
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cohort Studies; Combined Modality Therapy; Cytokines; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Prognosis; Recurrence; Remission Induction; Sarcoma, Ewing; Survival Analysis; Whole-Body Irradiation

1993
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Cancer, 1994, Apr-01, Volume: 73, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia

1994
[Disease-free survival in a patient with squamous cell lung carcinoma following complete response with the combination chemotherapy of cisplatin and etoposide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:7

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Prognosis; Remission Induction; Tegafur; Uracil

1993
Case report: pulmonary blastoma in children--response to chemotherapy.
    Medical and pediatric oncology, 1996, Volume: 26, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Pulmonary Blastoma; Vincristine

1996
Intense gallbladder uptake associated with chemotherapy. An unusual finding in pediatric skeletal scintigraphy.
    Clinical nuclear medicine, 1995, Volume: 20, Issue:11

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Child; Etoposide; Female; Gallbladder; Humans; Ifosfamide; Liver; Male; Osteosarcoma; Radionuclide Imaging; Sarcoma, Ewing; Technetium Tc 99m Medronate; Tissue Distribution

1995
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
    Blood, 1996, Jun-15, Volume: 87, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine

1996
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:7

    Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine

1996
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
    Minerva pediatrica, 1995, Volume: 47, Issue:11

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine

1995
Gestational trophoblastic disease presenting as a large metastasis to the finger.
    Gynecologic oncology, 1996, Volume: 63, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fingers; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine

1996
[A pilot study of low dose etoposide therapy for recurrenced prostate cancer in complicated over 75 years old stage D2 cases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prostatic Neoplasms

1996
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
    Journal of neuro-oncology, 1997, Volume: 32, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine

1997
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
    Minerva chirurgica, 1997, Volume: 52, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leg; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine

1997
[A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:15

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Remission Induction; Stomach Neoplasms; Vincristine

1997
The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Mesna; Middle Aged; Neuroectodermal Tumors, Primitive; Neutropenia; Sarcoma, Ewing; Vincristine

1997
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Fever; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neutropenia; Osteosarcoma; Pilot Projects; Thrombocytopenia

1998
Postsurgical etoposide-ifosfamide regimen in poor-risk nonmetastatic osteogenic sarcoma.
    American journal of clinical oncology, 1998, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Osteosarcoma; Prospective Studies; Remission Induction; Salvage Therapy

1998
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapy.
    American journal of hematology, 1998, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Tomography, X-Ray Computed; Vincristine

1998
[Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
    Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Urinary Bladder Neoplasms; Vinblastine

1998
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma.
    British journal of cancer, 1999, Volume: 79, Issue:7-8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Recurrence; Retrospective Studies

1999
The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity.
    International journal of oncology, 1999, Volume: 15, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Cycle; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Drug Administration Schedule; Enzyme Inhibitors; Etoposide; Genes, p16; Genetic Therapy; Humans; Osteosarcoma; Topoisomerase II Inhibitors

1999
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Purging; Bone Neoplasms; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 22; Combined Modality Therapy; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Mesna; Neoplasm Proteins; Neoplastic Cells, Circulating; Oncogene Proteins, Fusion; Paired Box Transcription Factors; PAX3 Transcription Factor; Proto-Oncogene Protein c-fli-1; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma, Alveolar; RNA-Binding Protein EWS; Sarcoma, Ewing; Sensitivity and Specificity; Soft Tissue Neoplasms; Transcription Factors; Translocation, Genetic; Vincristine

1999
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; L-Lactate Dehydrogenase; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Sarcoma, Ewing; Vincristine

2000
Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.
    European journal of cancer (Oxford, England : 1990), 2000, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Pilot Projects; Prospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Survival Analysis; Vincristine

2000
Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.
    Medical and pediatric oncology, 2000, Volume: 34, Issue:4

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Forecasting; Humans; Infant; Multicenter Studies as Topic; Neuroblastoma; Observer Variation; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Retrospective Studies; Statistics as Topic; Treatment Outcome

2000
High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
    Southern medical journal, 2000, Volume: 93, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Radionuclide Imaging; Receptors, Somatostatin; Somatostatin

2000
Long-term survival following extra-neural metastasis from a pineoblastoma.
    Journal of neuro-oncology, 2000, Volume: 48, Issue:2

    Topics: Acetabulum; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Ilium; Pineal Gland; Pinealoma; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Skin Neoplasms; Thigh; Vincristine

2000
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine

2001
Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 27, Issue:6

    Topics: Antigens, CD34; Antineoplastic Agents; Bone Marrow Neoplasms; Bone Neoplasms; Carboplatin; Child; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Remission Induction; Retinoblastoma; Thiotepa; Transplantation, Autologous; Vincristine

2001
Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
    Cancer gene therapy, 2001, Volume: 8, Issue:4

    Topics: Adenoviridae; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Survival; DNA-Binding Proteins; Doxorubicin; E2F Transcription Factors; E2F1 Transcription Factor; Enzyme Inhibitors; Etoposide; Gene Expression; Gene Transfer Techniques; Humans; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Proteins; Osteosarcoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Topoisomerase II Inhibitors; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2001
Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction: a case report and literature review.
    Medical oncology (Northwood, London, England), 2001, Volume: 18, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chromosome Aberrations; Chromosomes, Human, Pair 12; Diagnosis, Differential; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Paclitaxel; Pelvic Neoplasms; Seminoma

2001
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine

2002
Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Retrospective Studies; Survival Rate; Treatment Outcome

2002
Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2002, Volume: 178, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Time Factors; Vincristine

2002
Primary treatment of pelvic osteosarcoma. Report of five cases.
    Cancer, 1992, Mar-01, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fluid Therapy; Follow-Up Studies; Humans; Ifosfamide; Injections, Intra-Arterial; Lung Neoplasms; Osteosarcoma; Pelvic Bones; Radiotherapy Dosage; Survival Rate

1992
[Solitary osseous metastasis in a patient with germ cell tumor--successful chemotherapy].
    Der Urologe. Ausg. A, 1992, Volume: 31, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Male; Orchiectomy; Shoulder Joint; Teratoma; Testicular Neoplasms

1992
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Sarcoma, Ewing; Treatment Outcome

1992
Ewing's sarcoma: experience with 12 cases.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine

1992
Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation.
    Journal of neuro-oncology, 1992, Volume: 13, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Graft vs Host Disease; Humans; Lymphatic Metastasis; Male; Medulloblastoma; Prevalence; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine

1992
Treatment for stage III-IV neuroblastoma patients: initial response to chemotherapy evaluated by biochemical parameters.
    Acta paediatrica Scandinavica, 1991, Volume: 80, Issue:10

    Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Homovanillic Acid; Humans; Infant; Male; Mediastinal Neoplasms; Neuroblastoma; Vanilmandelic Acid; Vincristine

1991
Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
    The American journal of pediatric hematology/oncology, 1991,Fall, Volume: 13, Issue:3

    Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Gangliosides; Humans; Mandibular Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Remission Induction; Retinoblastoma; Transplantation, Autologous; Vincristine; Whole-Body Irradiation

1991
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
    Clinical orthopaedics and related research, 1991, Issue:270

    Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Lengthening; Bone Neoplasms; Bone Transplantation; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Italy; Male; Methotrexate; Osteosarcoma; Osteotomy; Postoperative Care; Preoperative Care; Prognosis; Prostheses and Implants; Survival Rate

1991
[Two cases of Ewing's sarcoma originating from the adult rib].
    Nihon Kyobu Shikkan Gakkai zasshi, 1991, Volume: 29, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Ribs; Sarcoma, Ewing

1991
Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
    Cancer, 1991, Nov-01, Volume: 68, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leg; Male; Neoplasm Recurrence, Local; Osteosarcoma; Probability; Proportional Hazards Models; Remission Induction

1991
[Complete remission of bone metastasis of bladder cancer treated by cisplatin-etoposide therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6

    Topics: Acetabulum; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Etoposide; Humans; Male; Remission Induction; Urinary Bladder Neoplasms

1991
Use of MR imaging to assess results of chemotherapy for Ewing sarcoma.
    AJR. American journal of roentgenology, 1990, Volume: 155, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Evaluation Studies as Topic; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Sarcoma, Ewing

1990
[Relapsed stage I neuroblastoma successfully treated by allogeneic bone marrow transplantation in second remission: case report of a 7-year-old girl].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9

    Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Melphalan; Neuroblastoma; Remission Induction; Whole-Body Irradiation

1990
Combination therapy with platinum and etoposide of brain metastases from breast carcinoma.
    Cancer investigation, 1990, Volume: 8, Issue:3-4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Platinum; Regression Analysis; Remission Induction

1990
Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy.
    Cancer, 1990, Feb-15, Volume: 65, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Osteosarcoma

1990
High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:2

    Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Coccyx; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Reoperation; Testicular Neoplasms; Vinblastine

1986
Etoposide and mitomycin-C in pretreated metastatic breast cancer.
    Tumori, 1989, Oct-31, Volume: 75, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis

1989
[Efficacy of etoposide in bone metastasis of breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:2

    Topics: Bone Neoplasms; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Radiography

1989
Etoposide (VP16-213) in the treatment of advanced nasopharyngeal carcinoma.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:4

    Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms

1988
Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced disease.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1988, Volume: 110

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms

1988